These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26323260)

  • 21. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
    Huang M; Jin J; Sun H; Liu GT
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.
    Wei N; Sun H; Wang F; Liu G
    Cancer Chemother Pharmacol; 2011 May; 67(5):1017-25. PubMed ID: 20640574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
    Wang S; Yang Y; Wang Y; Chen M
    Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
    Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
    Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum.
    Yang L; Wei DD; Chen Z; Wang JS; Kong LY
    Phytomedicine; 2011 Jun; 18(8-9):710-8. PubMed ID: 21306883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG; LeBlanc GA
    Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins.
    Kasaian J; Mosaffa F; Behravan J; Masullo M; Piacente S; Ghandadi M; Iranshahi M
    Fitoterapia; 2015 Jun; 103():149-54. PubMed ID: 25843566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.
    Kim KY; Kim SH; Yu SN; Park SK; Choi HD; Yu HS; Ji JH; Seo YK; Ahn SC
    Mol Med Rep; 2015 Aug; 12(2):1898-904. PubMed ID: 25892525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
    Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH
    Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.
    Liu R; Zhang Y; Chen Y; Qi J; Ren S; Xushi MY; Yang C; Zhu H; Xiong D
    J Pharm Sci; 2010 Jul; 99(7):3266-75. PubMed ID: 20112430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
    Xue P; Yang X; Liu Y; Xiong C; Ruan J
    Biomed Pharmacother; 2014 Oct; 68(8):1049-56. PubMed ID: 25455158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.